Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
CANCER SUPPORT FUND OF CENTRAL MASS
Financial strength (30%)
68/100
Reliability (20%)
45/100
Effectiveness (25%)
73/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$63K
Total Revenue
$35K
Total Expenses
$103K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
93.7%
Fundraising Efficiency
49.2%
Operating Reserve
35.63x
Liability-to-Asset
0.0%
Revenue Diversification
74.1%
Compared with Peers
FY 2025
Compared with 783 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
93.7% | 79.3% |
P10P90
|
Above median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
49.2% | 37.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
35.6 mo | 20.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
74.1% | 99.4% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
27.2% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
38.9% | -2.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
45.1% | 12.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $63K | $35K | $103K | 93.7% | — |
| 2024 | $50K | $25K | $75K | 93.3% | — |
| 2023 | $40K | $44K | $50K | 96.1% | — |
| 2022 | $52K | $26K | $54K | 91.4% | — |
| 2021 | $44K | $13K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.